Public-domain · open source
OpenJurist
← 893 F.3d 941 - McDaniel v. Upsher-Smith Labs., Inc.

McDaniel v. Upsher-Smith Labs., Inc.’s Empirical Analysis

893 F.3d 941 · 2018

Citation profile

9
cited by 9 later decisions
1
cited 1 times by the Supreme Court
July 2025
most recently cited

Relationships

Applies 21 U.S.C. § 337 (Federal Food, Drug, and Cosmetic Act) · 21 U.S.C. § 355 (Federal Food, Drug, and Cosmetic Act)

Relies on Hines v. Davidowitz · Florida Lime & Avocado Growers, Inc. v. Paul · Fidelity Federal Savings and Loan Association v. D Cuesta · Gade v. National Solid Wastes Management Assn. · Buckman Company V.' Legal Committee

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 9 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “as a drug of last resort for patients suffering from ventricular fibrillation and ventricular tachycardia, both life-threatening heartbeat irregularities.”
    1 later decision quote this exact passage · from the majority

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.